Cargando…
Glycosaminoglycans and Glycomimetics in the Central Nervous System
With recent advances in the construction of synthetic glycans, selective targeting of the extracellular matrix (ECM) as a potential treatment for a wide range of diseases has become increasingly popular. The use of compounds that mimic the structure or bioactive function of carbohydrate structures h...
Autores principales: | Rowlands, Dáire, Sugahara, Kazuyuki, Kwok, Jessica C. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272379/ https://www.ncbi.nlm.nih.gov/pubmed/25706756 http://dx.doi.org/10.3390/molecules20033527 |
Ejemplares similares
-
Glycomimetic Peptides as Therapeutic Tools
por: Hoober, J. Kenneth, et al.
Publicado: (2023) -
Human Genetic Disorders and Knockout Mice Deficient in Glycosaminoglycan
por: Mizumoto, Shuji, et al.
Publicado: (2014) -
Strategies for the Development of Glycomimetic Drug Candidates
por: Hevey, Rachel
Publicado: (2019) -
Targeting Galectins With Glycomimetics
por: Bertuzzi, Sara, et al.
Publicado: (2020) -
Bioisosteres of Carbohydrate Functional Groups in Glycomimetic Design
por: Hevey, Rachel
Publicado: (2019)